Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis by Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, Mark Boguniewicz

Get full text

Efficacy and Safety of Ruxolitinib Cream in Atopic Dermatitis Based on Previous Medication History by Andrew Blauvelt, Howard Kallender, Daniel Sturm, Qian Li, Haobo Ren, Lawrence F. Eichenfield

Get full text

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives by Lawrence F. Eichenfield, Jinan Liu, Simran Marwaha, James Piercy, Daniel Sturm, Peter Anderson

Get full text

Treatment preferences among patients with mild-to-moderate atopic dermatitis by Kelley Myers, Jonathan I. Silverberg, Shreekant Parasuraman, Anna Pierce, Lawrence F. Eichenfield, Christine Poulos

Get full text

Wrapping technique for infants and toddlers undergoing dermatology clinic procedures by Elana P. Kleinman, BS, Lawrence F. Eichenfield, MD, Dawn Z. Eichenfield, MD, PhD

Get full text

Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies by Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F. Eichenfield

Get full text

Pediatric chronic hand eczema: Epidemiology, clinical presentation, and managementCapsule Summary by Michael A. Haft, MD, Helen H. Park, MD, Stephanie S. Lee, MD, Jessica M. Sprague, MD, Lawrence F. Eichenfield, MD

Get full text

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical tria... by Carsten Flohr, Michael J. Cork, Michael R. Ardern-Jones, Lawrence F. Eichenfield, Sébastien Barbarot, Claire Feeney, Ricardo Rojo, Irina Lazariciu, John Nesnas

Get full text

Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database by Lawrence F. Eichenfield, Marco DiBonaventura, Jason Xenakis, Marie-Helene Lafeuille, Mei Sheng Duh, Iman Fakih, Mark Levenberg, Joseph C. Cappelleri, Vanja Sikirica

Get full text

Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years by Andreas Wollenberg, Masanori Ikeda, Chia-Yu Chu, Lawrence F. Eichenfield, Marieke M. B. Seyger, Apurva Prakash, Robinette Angle, Danting Zhu, Marco Pontes, Amy S. Paller

Get full text

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations by Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

Get full text

Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis by Lawrence F. Eichenfield, Linda F. Stein Gold, Charles Lynde, Lyn Guenther, Shoshana Greenberger, Chia-Yu Chu, Zara Ghodsi, Bonnie Vlahos, Paul Sanders, Amy Cha, Juliana M. Canosa

Get full text

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis by Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit

Get full text

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale by Amy S Paller, Emma Guttman-Yassky, Katrina Abuabara, Jonathan I Silverberg, Eric L Simpson, Lawrence F. Eichenfield, Robert Bissonnette, James Krueger, John E. Harris, Laura Dalfonso, Stephanie E Watkins, Julie M Crawford, D Thaçi

Get full text

Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus by Mark Boguniewicz, MD, Moise L. Levy, MD, Lawrence F. Eichenfield, MD, Christine T. Lauren, MD, MHA, Donald Y.M. Leung, MD, PhD, Lynda C. Schneider, MD, Elaine C. Siegfried, MD, Wynnis L. Tom, MD, Amy S. Paller, MD

Get full text

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study by Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R. Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger

Get full text

Atopic eczema patients and healthcare professionals join forces in Malta by Jean‐François Stalder, Hélène Aubert, Sebastien Barbarot, Jean‐Marc Chavigny, Mette Deleuran, Lawrence F. Eichenfield, May El Hachem, Peter Lio, Danielle Marcoux, Christine Roxburgh, Markéta Saint Aroman, Fanny Sentenac, Alain Taieb, Kathrin Thormann, Christian Vestergaard, Gabriele Wiener‐Hemme, Andreas Wollenberg

Get full text

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis by Leon H. Kircik, Linda Stein Gold, Michael Gold, Jonathan S. Weiss, Julie C. Harper, James Q. Del Rosso, Christopher G. Bunick, Neal Bhatia, Emil A. Tanghetti, Lawrence F. Eichenfield, Hilary Baldwin, Zoe D. Draelos, Valerie D. Callender, George Han, Melinda J. Gooderham, Neil Sadick, Mary P. Lupo, Edward (Ted) Lain, William Philip Werschler

Get full text